Skip to content.

Companies

Acquired by Apple

Acquired by Apple

Acquired by Capital D

Acquired by Capital D

Acquired by Oracle

Acquired by Oracle

Acquired by Siemens

Acquired by Siemens

Acquired by ERT Clinical

Acquired by ERT Clinical

LON: AREC

LON: AREC

NASDAQ: ORTX

NASDAQ: FRLN

NASDAQ: ACHL

NASDAQ: MGTX

Acquired by Facebook

NASAQ: BKNG

  • DeepTech investments
  • Assets under management
    $1bn+
    Focused on early-stage B2B software and healthcare
  • Established
    1996
    Over 287 years in your corner
  • Dedicated fund
    $150m
    UCL Tech Fund focused on early stage deeptech opportunities

Featured investments

What do Founders worry about?

Reflections on CogX Founder Roundtable

Read the article >

A computing impasse – the investments we make now will define our future

Read the article >

Why we invested in Brytlyt?

Read the article >
Companies
  • Achilles Therapeutics
    Biopharmaceutical company developing precision T cell therapies
    Sector: DeepTech
    Status: Nasdaq IPO
  • Antenova
    Develops high performance antennas and RF antenna modules for wireless communication and consumer electronic devices
    Sector: DeepTech
    Status: Exited
  • Gene therapy company developing disease-transformative medicines for ciliopathies
    Sector: DeepTech
    Status: Early Stage
  • Bloomsbury AI
    Enabling everyone to easily create their own question-answering system
    Sector: DeepTech
    Status: Exited
  • Fuel cell company on a mission to help the world achieve net zero
    Sector: DeepTech
    Status: Growth
  • Next generation data solution making deep learning accessible
    Sector: DeepTech
    Status: Early Stage
  • Climate tech startup utilising AI to achieve operational efficiency in energy intensive industries
    Sector: DeepTech
    Status: Early Stage
  • Transforming interventional cardiology with optical-fibre based sensors
    Sector: DeepTech
    Status: Early Stage
  • Immuno-oncology company targeting cancer with the IgE class of antibodies
    Sector: DeepTech
    Status: Early Stage
  • Freeline Therapeutics
    Biopharmaceutical company focused on the development of liver-directed gene therapies
    Sector: DeepTech
    Status: Nasdaq IPO
  • Grapeshot
    A contextual intelligence platform that empowers brands to deliver relevance to every customer experience
    Sector: DeepTech
    Status: Exited
  • Synthetic data platform
    Sector: DeepTech
    Status: Early Stage
  • DevOps tool that rapidly builds NLP models that continuously improve
    Sector: DeepTech
    Status: Early Stage
  • Cloud-native automated reasoning platform to ensure algorithms are safe, explainable and fair
    Sector: DeepTech
    Status: Early Stage
  • Developing a new type of all silicon non-volatile memory
    Sector: DeepTech
    Status: Early Stage
  • Vertically integrated, clinical stage gene therapy company
    Sector: DeepTech
    Status: Nasdaq IPO
  • Immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer
    Sector: DeepTech
    Status: Early Stage
  • AI powered platform that unifies large datasets and automatically optimises sales performance for marketplace sellers
    Sector: DeepTech
    Status: Early Stage
  • Builds a new era of cloud connected endoscopy
    Sector: DeepTech
    Status: Early Stage
  • Orchard Therapeutics
    Biotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
    Sector: DeepTech
    Status: Nasdaq IPO
  • Panangium Therapeutics
    Biologic for retinal disease targeting a novel alternative pathway to VEGF
    Sector: DeepTech
    Status: Early Stage
  • Perpetuum
    Condition monitoring system for railways
    Sector: DeepTech
    Status: Exited
  • Using disruptive theory to unlock the power of quantum computing
    Sector: DeepTech
    Status: Early Stage
  • PSE
    Process modelling software and model-based innovation services
    Sector: DeepTech
    Status: Exited
  • Data and analytics company pioneering contextual decision intelligence
    Sector: DeepTech
    Status: Growth
  • Quell Therapeutics
    Cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions
    Sector: DeepTech
    Status: Growth
  • Global experts in deep learning and speech recognition
    Sector: DeepTech
    Status: Growth
  • EdTech platform connecting tutors in the developing countries to students in developed economies
    Sector: DeepTech
    Status: Early Stage

Let’s talk